国际妇产科联盟《妊娠滋养细胞疾病诊治指南(2025)》解读

Chinese Journal of Practical Gynecology and Obstetrics ›› 2025, Vol. 41 ›› Issue (10) : 1012-1017.

PDF(907 KB)
PDF(907 KB)
Chinese Journal of Practical Gynecology and Obstetrics ›› 2025, Vol. 41 ›› Issue (10) : 1012-1017. DOI: 10.19538/j.fk2025100111

Author information +
History +

Cite this article

Download Citations

References

[1]
王丽娟, 李睿歆, 林仲秋. 2021 FIGO《妊娠滋养细胞疾病诊治指南》解读[J]. 中国实用妇科与产科杂志, 2022, 38(2):181-185. DOI:10.19538/j.fk202202113.
[2]
王丽娟, 凌小婷, 黄晓欣, 等. 《EOTTD-ESGO-GCIG-ISSTD妊娠滋养细胞疾病诊治实践指南》解读[J]. 中国实用妇科与产科杂志, 2025, 41(8):830-835.DOI:10.19538/j.fk2025080113.
[3]
Kohorn EI, Goldstein DP, Hancock BW, et al. Workshop Report: Combining the staging system of the International Federation of Gynecology and Obstetrics with the scoring system of the World Heath Organization for Trophoblastic Neoplasia. Report of the Working Committee of the International Society for the Study of Trophoblastic Disease and the International Gynecologic Cancer Society[J]. Int J Gynecol Cancer, 2000, 10(1):84-88. DOI:10.1046/j.1525-1438.2000.00002.x
[4]
Kohorn EI. The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: Description and critical assessment[J]. Int J Gynecol Cancer, 2001, 11,73-77. DOI:10.1046/j.1525-1438.2001.011001073.x.
[5]
Ngan HY, Seckl MJ, Berkowitz RS, et al. Update on the diagnosis and management of gestational trophoblastic disease[J]. Int J Gynecol Obstet, 2018, 143(Suppl 2):79-85. DOI:10.1002/ijgo.12615.
[6]
Ngan HY, Seckl MJ, Berkowitz RS, et al. Diagnosis and management of gestational trophoblastic disease: 2021 update[J]. Int J Gynecol Obstet, 2021, 155(Suppl 1):86-93. DOI:10.1002/ijgo.13877.
[7]
中国抗癌协会妇科肿瘤专业委员会. 妊娠滋养细胞疾病诊断与治疗指南(2021年版)[J]. 中国癌症杂志, 2021, 31(6):520-532. DOI:10.19401/j.cnki.1007-3639.2021.06.10.
[8]
Lok C, van Trommel N, Massuger L, et al. Practical clinical guidelines of the EOTTD for treatment and referral of gestational trophoblastic disease[J]. Eur J Cancer, 2020, 130:228-240. DOI:10.1016/j.ejca.2020.02.011.
[9]
Lok C, van Trommel N, loana Braicu E, et al. Practical guidelines for the treatment of gestational trophoblastic disease: collaboration of the European Organisation for the treatment of trophoblastic disease (EOTTD)-European Society of Gynaecologic Oncology (ESGO)-Gynecologic Cancer InterGroup (GCIG)-International Society for the study of Trophoblastic Disease (ISSTD)[J]. J Clin Oncol, 2025, 43(18):2119-2128. DOI:10.1200/JCO-24-02326.
[10]
Yu H, Li J, Zhu T, et al. Evaluation and influence of lung metastasis on patient outcome in gestational trophoblastic neoplasia: A 10-year study at a single institution[J]. Eur J Obstet Gynecol Reprod Biol, 2020, 251:162-166. DOI:10.1016/j.ejogrb.2020.05.046.
[11]
Yang J, Xiang Y, Wan X, et al. The prognosis of gestational trophoblastic neoplasia patient with residual lung tumor after completing treatment[J]. Gynecol Oncol, 2006, 103:479-482. DOI:10.1016/j.ygyno.2006.03.015.
[12]
Powels T, Savage P, Short D, et al. Residual lung lesions after completion of chemotherapy for gestational trophoblastic neoplasia: should we operate?[J] Br J Cancer, 2006, 94:51-54. DOI:10.1038/sj.bjc.6602899.
[13]
Frijstein MM, Lok C, van Trommel NE, et al. Lung metastases in low-risk gestational trophoblastic neoplasia: a retrospective cohort study[J]. BJOG, 2020, 127:389-395.DOI:10.1111/1471-0528.16036.
[14]
Vree M, van Trommel N, Kenter G, et al. The influence of lung metastases on the clinical course of gestationla trophoblastic neoplasia: a historical cohort study[J]. BJOG, 2016, 123:1839-1845. DOI:10.1111/1471-0528.13622.

Funding

Guangdong Province Health Appropriate Technology Promotion Project(202303271111293099)
Guangdong Provincial Department of Education 2022 Provincial Continuing Education Quality Improvement Project Construction Category(JXJYGC2022GX263)
PDF(907 KB)

Accesses

Citation

Detail

Sections
Recommended

/